Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5071-5080 of 11729

Edit search filters
  1. Phase 3 Study Of MRTX849 With Cetuximab Vs Chemotherapy In Patients With Advanced Colorectal Cancer With KRAS G12C Mutation

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study Of Tucatinib With Trastuzumab And MFOLFOX6 Versus Standard Of Care Treatment In First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study To Evaluate Radiation Dermatitis Severity In Irradiated Skin Protected By An Agent Versus Uncovered Skin

    Rochester, MN

  4. Health Coaching to Improve Self-Management in Thoracic Transplant Candidates

    Rochester, MN

  5. A Study to Evaluate S-Adenosyl-L-Methionine for the Treatment of Hot Flashes

    Rochester, MN

  6. A Study Of LensOne Prosthetic Capsule In Aphakic Patients Lacking Capsular Support

    Rochester, MN

  7. K-5475-013 INSIGNIA-PH-COPD: A Study Of The Efficacy And Safety Of MK-5475 (An Inhaled SGC Stimulator) In Adults With PH-COPD

    Rochester, MN

  8. A Phase 2, Open-Label Study Of DISC-3405 In Participants With Polycythemia Vera (PV)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Phase III Study Of Datopotamab Deruxtecan Versus Docetaxel In Previously Treated TROP2-positive Advanced Or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

    Eau Claire, WI, Jacksonville, FL, Rochester, MN

  10. Rituximab With Or Without Stem Cell Transplant In Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma In First Complete Remission

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer